American cell therapies company selects ValGenesis VLMS to digitize multiple validation lifecycle processes
San Francisco, January 25, 2021: ValGenesis Inc., a market leader…
International biosciences company to digitize validation processes for its clients across 40 countries, driven by ValGenesis VLMS
San Francisco, January 20, 2021: ValGenesis, Inc., a market leader…
Pioneering Gene Therapy Company selects ValGenesis’s SaaS platform to digitize its global validation programs
San Francisco, January 6, 2021: ValGenesis, Inc., a market leader…
ValGenesis collaborates with Biocon Biologics for digital validation across multiple sites
San Francisco, December 15, 2020: ValGenesis Inc., a market leader…
Global medical devices company went live with paperless validation process across the organization, powered by ValGenesis SaaS platform
San Francisco, December 7, 2020: ValGenesis, Inc., a market leader…
Global Top 5 life science organization selects ValGenesis to digitize and standardize validation processes across its global sites
San Francisco, November 18, 2020: ValGenesis, Inc., a market leader…
Global clinical-stage biopharmaceutical company selects ValGenesis to digitize its corporate validation process
San Francisco, October 27, 2020: ValGenesis, Inc., a market leader…
A Top10 US-based injectable company selects ValGenesis to digitize its corporate validation process
San Francisco, October 19, 2020: ValGenesis, Inc., a market leader…
Dr. Reddy’s Laboratories goes paperless in validation with ValGenesis VLMS
San Francisco, October 5, 2020 ValGenesis Inc., a market leader…
